Actualizado 15/01/2013 21:49
- Comunicado -

Amyvid (Florbetapir (18F)) Solution for Injection Approved in European Union for Use in Patients with Cognitive Impairme

Refer to: Celeste Stanley,+ 317-478-0263 (mobile), stanley_celeste_a@lilly.com[mailto:stanley_celeste_a@lilly.com]

(Logo: http://photos.prnewswire.com/prnh/200312... [http://photos.prnewswire.com/prnh/200312...] )

Contenido patrocinado